Stockscreener 앱 받기
25.32
0.69%
-0.1074
전일 마감가:
$25.43
열려 있는:
$25.59
하루 거래량:
34,504
Relative Volume:
0.14
시가총액:
$1.24B
수익:
-
순이익/손실:
$-82.83M
주가수익비율:
-20.40
EPS:
-1.2413
순현금흐름:
$-72.22M
1주 성능:
+1.34%
1개월 성능:
-12.52%
6개월 성능:
+10.28%
1년 성능:
+126.71%
1일 변동 폭
$24.69
$25.76
1주일 범위
$23.70
$26.48
52주 변동 폭
$9.80
$30.03
Enliven Therapeutics Inc Stock (ELVN) Company Profile
명칭
Enliven Therapeutics Inc
전화
720-647-8519
주소
6200 LOOKOUT ROAD, BOULDER
ELVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| ELVN | 25.27 | 1.24B | 0 | -82.83M | -72.22M | -1.2413 |
| VRTX | 447.39 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.98 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 592.15 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.86 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 104.13 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-03-29 | 개시 | Jefferies | Buy |
Enliven Therapeutics Inc 주식(ELVN)의 최신 뉴스
Short Interest in Enliven Therapeutics, Inc. (NASDAQ:ELVN) Increases By 6.1% - MarketBeat
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Shares Bought by First Turn Management LLC - MarketBeat
Robert W. Baird Issues Positive Forecast for Enliven Therapeutics (NASDAQ:ELVN) Stock Price - Defense World
Enliven Therapeutics has cash runway into late 2026 - BizWest
Robert W. Baird Forecasts Strong Price Appreciation for Enliven Therapeutics (NASDAQ:ELVN) Stock - MarketBeat
RA Capital Management, L.P. Reduces Stake in Enliven Therapeutics Inc. - GuruFocus.com
Citadel Advisors LLC Adjusts Stake in Enliven Therapeutics Inc - GuruFocus.com
COMMODORE CAPITAL LP Expands Stake in Enliven Therapeutics Inc - GuruFocus.com
Enliven Therapeutics Reports Q3 Results and Clinical Progress - TipRanks
Polar Capital Holdings Plc's Strategic Acquisition in Enliven Th - GuruFocus.com
Enliven Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
(ELVN) Investment Analysis and Advice - Stock Traders Daily
Enliven Therapeutics to Present at the Jefferies London Healthcare Conference - StockTitan
How to Take Advantage of moves in (ELVN) - Stock Traders Daily
Jones Trading Initiates Coverage of Enliven Therapeutics (ELVN) with Buy Recommendation - MSN
This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Enliven Therapeutics CFO Benjamin Hohl sells shares worth $178,484 By Investing.com - Investing.com South Africa
Enliven Therapeutics CFO Benjamin Hohl sells shares worth $178,484 - Investing.com
Enliven Therapeutics (ELVN) Price Target Increased by 10.75% to 35.02 - MSN
Enliven Therapeutics CFO sells $24,422 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics CFO sells $24,422 in stock - Investing.com
Enliven Therapeutics chief medical officer sells $24,482 in stock By Investing.com - Investing.com Canada
Enliven Therapeutics chief medical officer sells $24,482 in stock - Investing.com India
Enliven Therapeutics COO Anish Patel sells $21,482 in stock - Investing.com
Enliven Therapeutics COO Anish Patel sells $21,482 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics' chief scientific officer sells $25,412 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics CEO Kintz sells $27,722 in stock - Investing.com
Enliven Therapeutics' chief scientific officer sells $25,412 in stock - Investing.com India
Enliven Therapeutics director Heyman sells $47,104 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics CEO Kintz sells $27,722 in stock By Investing.com - Investing.com Australia
Enliven Therapeutics director Heyman sells $47,104 in stock - Investing.com India
Anish Patel Sells 716 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - MarketBeat
When (ELVN) Moves Investors should Listen - Stock Traders Daily
Enliven Therapeutics, Inc. (ELVN) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
ELVN stock soars to 52-week high, reaching $28.66 By Investing.com - Investing.com Australia
Enliven Therapeutics (NASDAQ:ELVN) Reaches New 52-Week HighHere's Why - MarketBeat
Richard A. Heyman Sells 1,270 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stock - MarketBeat
Enliven Therapeutics Inc [ELVN] Insider Lyssikatos Joseph P sells 37,878 Shares - Knox Daily
Enliven Therapeutics Inc (ELVN) stock analysis: A simple moving average approach - US Post News
Financial Metrics Check: Enliven Therapeutics Inc (ELVN)’s Ratios for Trailing Twelve Months - The Dwinnex
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Short Interest Update - MarketBeat
Enliven Therapeutics, Inc. Is a Great Choice for 'Trend' Investors, Here's Why - Benzinga
Insider Selling: Enliven Therapeutics, Inc. (NASDAQ:ELVN) Director Sells 10,420 Shares of Stock - MarketBeat
Enliven Therapeutics executive sells over $1.4 million in company stock - Investing.com India
Enliven Therapeutics director sells over $290k in company stock - Investing.com
Enliven Therapeutics director sells over $290k in company stock By Investing.com - Investing.com UK
Enliven Therapeutics (NASDAQ:ELVN) Trading Down 5.6%What's Next? - MarketBeat
Enliven Therapeutics CFO sells over $300k in company stock By Investing.com - Investing.com South Africa
Enliven Therapeutics Inc (ELVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
0.16%
자본화:
|
볼륨(24시간):